Looking Into Gilead Sciences's Recent Short Interest

Benzinga02:00

Gilead Sciences, Inc. (NASDAQ:GILD) Is a Favorite Amongst Institutional Investors Who Own 86%

Simply Wall StJan 7 21:48

RBC Trims Price Target on Gilead Sciences to $83 From $84, Keeps Sector Perform Rating

MT NewswiresJan 7 20:04 · Ratings

Hookipa Shareholder Gilead Sciences to Back Poolbeg Merger

MT NewswiresJan 7 17:35

If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today

BenzingaJan 7 06:15

FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development

Seeking AlphaJan 7 01:52